Ignite Creation Date:
2024-05-06 @ 1:27 PM
Last Modification Date:
2024-10-26 @ 1:15 PM
Study NCT ID:
NCT04038502
Status:
RECRUITING
Last Update Posted:
2023-11-01
First Post:
2019-07-26
Brief Title:
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor:
VA Office of Research and Development
Organization:
VA Office of Research and Development
Conditions & Keywords Data
Conditions:
| Name |
|---|
| RAD51B RAD51C RAD51D or RAD54L Mutations |
| Metastatic Castrate Resistant Prostate Cancer |
| BARD1 BRCA1 BRCA2 BRIP1 CHEK1 FANCL PALB2 |
Keywords:
| Name | View |
|---|---|
| metastatic prostate cancer | View |